Viewing Study NCT01169168


Ignite Creation Date: 2025-12-24 @ 5:49 PM
Ignite Modification Date: 2025-12-27 @ 2:05 AM
Study NCT ID: NCT01169168
Status: UNKNOWN
Last Update Posted: 2010-07-26
First Post: 2010-07-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome (SIRS), Sepsis or Chronicle Liver Disease on Intensive Care Units (ICU)
Sponsor: Johann Wolfgang Goethe University Hospital
Organization:

Study Overview

Official Title: Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome, Sepsis, Chronicle Liver Disease or After Lysis on Intensive Care Units
Status: UNKNOWN
Status Verified Date: 2010-07
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: In this study patients with

1. chronicle liver diseases

* primary biliary cirrhosis
* primary sclerosing cholangitis
* alcoholic liver cirrhosis
* hepatitis b or C
* Wilson's disease
* cryptogenic cirrhosis
2. Septic Inflammatory Response Syndrome (SIRS)

* sepsis
* septic shock
3. patients after lysis

should be included

Blood samples will be gathered from the patients to measure fibrinogen with 5 different methods.

The methods are:

* Clauss fibrinogen
* PT-Derived fibrinogen
* immunoturbidimetric method
* heat-precipitated fibrinogen
* Schulz fibrinogen

The result of these tests will be correlated with laboratory values which are gathered in routine and the clinical outcomes.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: